Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Danaher Purchases Life Science Businesses for US $1.1 Billion

By LabMedica International staff writers
Posted on 07 Sep 2009
Danaher Corp. More...
(DHR; Washington, DC, USA) will acquire life science instrumentation businesses from MDS Inc. (Mississauga, ON, Canada) and Life Technologies (Carlsbad, CA, USA). The company has signed a definitive agreement with MDS Inc. to acquire its analytical technologies division, which includes a 50% ownership position in Applied Biosystems (Foster City, CA, USA)/MDS Sciex joint venture (AB Sciex), a mass spectrometry business, and a 100% ownership position in the former Molecular Devices Corporation (Sunnyvale, CA, USA), a bioresearch and analytical instrumentation company.

In a separate but related transaction, Danaher signed a definitive agreement with Life Technologies Corp. to acquire the remaining 50% ownership position in AB Sciex. After completion of both transactions, Danaher will own outright AB Sciex and MDS. The aggregate purchase price for the combined transactions is $1.1 billion, including debt assumed and net of cash acquired.

The transaction with MDS Inc. is subject to approval of the MDS shareholders. Both transactions are subject to regulatory approval and customary closing conditions, including the absence of material adverse change with respect to the acquired businesses. Danaher expects the transactions to close in the fourth quarter of 2009.

The acquired businesses will operate within Danaher's medical technologies segment and will expand the segment's annual revenues by more than $650 million. Danaher's life sciences and diagnostics annual revenues will increase to more than $2 billion.

AB Sciex designs and manufactures mass spectrometers, and instruments used by clinicians and researchers to identify and quantify specific molecules in complex samples. Typical applications include diagnostics testing, drug development, food and environmental safety testing, and proteomics research. MDS supplies bioanalytical instrumentation.

Danaher designs, manufactures, and markets products and services to professional, medical, industrial, and commercial customers. Its portfolio of brands is well recognized in each of its markets.

Related Links:
Danaher Corp.
MDS Inc.
AB Sciex
Life Technologies Corp.
Molecular Devices Corporation



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.